Free Trial

Truist Financial Cuts Intuitive Surgical (NASDAQ:ISRG) Price Target to $605.00

Intuitive Surgical logo with Medical background
Remove Ads

Intuitive Surgical (NASDAQ:ISRG - Free Report) had its price objective reduced by Truist Financial from $666.00 to $605.00 in a research note released on Monday, MarketBeat Ratings reports. Truist Financial currently has a buy rating on the medical equipment provider's stock.

Other equities analysts have also issued reports about the company. Jefferies Financial Group raised their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Leerink Partners lifted their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Bernstein Bank upped their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. Raymond James raised their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Finally, Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $611.86.

View Our Latest Report on ISRG

Remove Ads

Intuitive Surgical Stock Up 0.1 %

NASDAQ ISRG traded up $0.68 during trading hours on Monday, reaching $492.49. 3,367,426 shares of the company were exchanged, compared to its average volume of 1,454,773. The stock has a market capitalization of $175.41 billion, a P/E ratio of 76.83, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical has a 1 year low of $364.17 and a 1 year high of $616.00. The business's 50 day simple moving average is $563.34 and its 200-day simple moving average is $531.34.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company's stock, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock worth $17,691,621 in the last 90 days. 0.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in ISRG. Howard Capital Management Group LLC raised its holdings in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock worth $1,044,000 after acquiring an additional 92 shares during the period. Principal Financial Group Inc. increased its position in Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock worth $295,938,000 after purchasing an additional 9,194 shares during the last quarter. Empowered Funds LLC raised its stake in Intuitive Surgical by 4.4% during the third quarter. Empowered Funds LLC now owns 8,177 shares of the medical equipment provider's stock worth $4,017,000 after purchasing an additional 345 shares during the period. Atlanta Consulting Group Advisors LLC acquired a new position in Intuitive Surgical in the 3rd quarter valued at about $505,000. Finally, Claro Advisors LLC grew its stake in shares of Intuitive Surgical by 34.3% in the 3rd quarter. Claro Advisors LLC now owns 1,213 shares of the medical equipment provider's stock valued at $596,000 after buying an additional 310 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads